Johnson & Johnson's vaccine is a one-dose shot using technology based on the development and production of adenovirus vectors, or gene carriers. The company has said the vaccine will be delivered at a price of no profit, regardless of where in the world it is being delivered, "as long as all these orders have been taken in the next few weeks and months."
The AstraZeneca-Oxford vaccine, which requires two doses, is priced at approximately $3 to $4, according to the Financial Times, citing supply deals agreed through to Oct. The U.K., Japan, Indonesia, Brazil, and Latin America excluding Brazil have all confirmed orders of at least 100 million doses. and India have both agreed to procure 500 million doses, the EU has reached a deal to buy 400 million, and the Covax facility has ordered 300 million. The vaccine candidate has secured a number of substantial deals with several countries. It is expected to add a final ingredient to its vials enabling them to be kept at regular fridge temperature when the vaccine nears regulatory approval, Reuters reported.
Data from late-stage trials should be made available before the end of the year.ĪstraZeneca said late last month that its vaccine candidate had produced a similar immune response in older and younger adults, and adverse responses to the vaccine among the elderly were also found to be lower.Įarlier this month, the British duo said it was keeping its vaccine frozen in large containers. British pharmaceutical giant AstraZeneca is developing its potential Covid-19 vaccine in collaboration with the University of Oxford.
0 kommentar(er)
